Table 1.
Compound or Intervention |
Treatment and Duration |
Tissue or Cell Line |
Animal Model or Human Subjects |
Enhance CISD2 Expression |
Reference |
---|---|---|---|---|---|
A. In Vitro Cell Study | |||||
Hesperetin | 10 and 30 μM for 24 h |
HEK293-CISD2 reporter cells |
CISD2 reporter |
[75] | |
Hesperetin -7-O-sulfate |
30 μM for 24 h |
HEK293-CISD2 reporter cells |
CISD2 reporter |
[75] | |
Curcumin | 1 μM for 24 h |
SH-SY5Y Rat primary astrocyte |
CISD2 mRNA | [38] | |
Wild bitter melon extract |
1 μg/mL for 24 h |
Astrocyte cell line |
LPS-challenged ACL | CISD2 mRNA | [73] |
α-Eleostearic acid | 0.28 μg/mL for 24 h |
Astrocyte cell line |
LPS-challenged ACL | CISD2 mRNA | [73] |
Sophoricoside | 10 and 30 μM for 24 h |
HEK293-CISD2 reporter cells |
CISD2 reporter |
[75] | |
Genistein | 10 and 30 μM for 24 h |
HEK293-CISD2 reporter cells |
CISD2 reporter |
[75] | |
Formononetin | 10 and 30 μM for 24 h |
HEK293-CISD2 reporter cells |
CISD2 reporter |
[75] | |
B. Animal Study | |||||
Exercise | |||||
Treadmill exercise for 8 weeks | Whole body (ventral view) |
CISD2 reporter mice |
CISD2 reporter |
[66] | |
Exercise with a running wheel for 4 weeks |
Skeletal muscle eWAT |
Male C57BL/6J mice | CISD2 protein |
[67] | |
Hesperetin | |||||
100 mg/kg/day (provided in food) for 5 months |
Heart Skeletal muscle |
Aged mice (26 months old) |
CISD2 protein |
[75] | |
100 mg/kg/day (provided in food) for 6 weeks |
Whole body (ventral view) |
CISD2 reporter mice |
CISD2 reporter |
[75] | |
Curcumin | |||||
40 mg/kg/day (i.p. injection) for 2 days |
Spinal cord | Aged mice (24 months old) |
CISD2 protein |
[38] | |
40 mg/kg/day (i.p. injection) for 2 days |
Spinal cord | Spinal cord hemisectionin mice |
CISD2 mRNA | [71] | |
Miscellaneous | |||||
Wild bitter melon extract |
500 mg/kg (i.p. injection) for single dose |
Spinal cord | Spinal cord hemisection in mice |
CISD2 mRNA and protein | [73] |
ESM powder | Diet with 10 g/kg ESM powder for 14 days |
Liver | Wistar rats | CISD2 mRNA | [74] |
HEM powder | Diet with 10 g/kg HEM powder for 14 days |
Liver | Wistar rats | CISD2 mRNA | [74] |
C. Human Study | |||||
RYGB surgery | 3 months post-RYGB |
Skeletal muscle | Obese females (BMI > 40 kg/m2) |
CISD2 protein |
[59] |